Pliant Therapeutics Inc (PLRX) — Financial Flexibility Index
Pliant Therapeutics Inc (PLRX) has a Financial Flexibility Index of -0.51x as of March 2026. Free cash flow of $-19.23 Million (operating CF $-19.23 Million minus capex $0.00) represents -1% of total liabilities ($37.43 Million). Check PLRX strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pliant Therapeutics Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Pliant Therapeutics Inc across 9 annual periods. See working capital to net assets of Pliant Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Pliant Therapeutics Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Pliant Therapeutics Inc. For the full company profile including market capitalisation, see PLRX market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.91x | $-127.96 Million | $-128.34 Million | $44.02 Million | ▼ -78.0% |
| 2024 | -1.63x | $-151.66 Million | $-155.50 Million | $92.87 Million | ▲ +45.4% |
| 2023 | -2.99x | $-115.44 Million | $-116.36 Million | $38.58 Million | ▼ -20.1% |
| 2022 | -2.49x | $-92.87 Million | $-94.63 Million | $37.27 Million | ▲ +24.9% |
| 2021 | -3.32x | $-73.49 Million | $-75.44 Million | $22.16 Million | ▼ -15.7% |
| 2020 | -2.87x | $-35.74 Million | $-37.27 Million | $12.46 Million | ▼ -19083.7% |
| 2019 | -0.01x | $-1.79 Million | $-2.75 Million | $119.50 Million | ▲ +96.1% |
| 2018 | -0.39x | $-26.00 Million | $-28.33 Million | $67.41 Million | ▲ +92.1% |
| 2017 | -4.87x | $-15.52 Million | $-16.92 Million | $3.19 Million | — |